In this manuscript, GMU demonstrated 1. brilacid
Post# of 72440
(Total Views: 342)
Posted On: 08/17/2021 9:12:11 AM
In this manuscript, GMU demonstrated
1. brilacidin exhibits robust inhibition of SARS-CoV-2 in Vero cells and Calu-3 cells, and in two strains of the virus. Likely to function as a viral entry inhibitor. the proposed mechanism of action for brilacidin includes affecting the integrity of the viral membrane and interfering with viral entry.
2. Brilacidin also exhibited an excellent synergistic inhibitory profile against SARS-CoV-2 in combination with remdesivir. Destabilizing viral integrity is a desirable antiviral property, especially in relation to pan-coronavirus agents, as the viral membrane is highly conserved and similar in construct across different coronavirus strains.
1. brilacidin exhibits robust inhibition of SARS-CoV-2 in Vero cells and Calu-3 cells, and in two strains of the virus. Likely to function as a viral entry inhibitor. the proposed mechanism of action for brilacidin includes affecting the integrity of the viral membrane and interfering with viral entry.
2. Brilacidin also exhibited an excellent synergistic inhibitory profile against SARS-CoV-2 in combination with remdesivir. Destabilizing viral integrity is a desirable antiviral property, especially in relation to pan-coronavirus agents, as the viral membrane is highly conserved and similar in construct across different coronavirus strains.
(4)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Ronald A Phillips
Scroll down for more posts ▼